Free Trial
→ DOJ Admits It In Court—Your Cash Can Be Seized Without Warning (From Priority Gold) (Ad)tc pixel

Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

Compare
CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
ATT
Abattis Bioceuticals
C$0.00
C$0.05
▼
C$0.74
N/AN/A1.42 million shsN/A
Tempus AI, Inc. stock logo
TEM
Tempus AI
$74.39
-11.0%		$63.82
$40.77
▼
$104.32
$13.45B3.546.18 million shs8.87 million shs
The 10 Best High-Yield Dividend Stocks for 2026 Cover
The 10 Best High-Yield Dividend Stocks for 2026

Discover the 10 Best High-Yield Dividend Stocks for 2026 and secure reliable income in uncertain markets. Download the report now to identify top dividend payers and avoid common yield traps.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
ATT
Abattis Bioceuticals
0.00%0.00%0.00%0.00%0.00%
Tempus AI, Inc. stock logo
TEM
Tempus AI
+9.03%-1.80%+29.29%+39.04%-8.85%
CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
ATT
Abattis Bioceuticals
C$0.00
C$0.05
▼
C$0.74
N/AN/A1.42 million shsN/A
Tempus AI, Inc. stock logo
TEM
Tempus AI
$74.39
-11.0%		$63.82
$40.77
▼
$104.32
$13.45B3.546.18 million shs8.87 million shs
The 10 Best High-Yield Dividend Stocks for 2026 Cover
The 10 Best High-Yield Dividend Stocks for 2026

Discover the 10 Best High-Yield Dividend Stocks for 2026 and secure reliable income in uncertain markets. Download the report now to identify top dividend payers and avoid common yield traps.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
ATT
Abattis Bioceuticals
0.00%0.00%0.00%0.00%0.00%
Tempus AI, Inc. stock logo
TEM
Tempus AI
+9.03%-1.80%+29.29%+39.04%-8.85%
CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
ATT
Abattis Bioceuticals
0.00
N/AN/AN/A
Tempus AI, Inc. stock logo
TEM
Tempus AI
2.41
Hold$71.05-4.49% Downside

Current Analyst Ratings Breakdown

Latest BGFD, TEM, MNKS, and ATT Analyst Ratings

DateCompanyBrokerageActionRatingPrice TargetDetails
10/1/2026
Tempus AI, Inc. stock logo
TEM
Tempus AI
Guggenheim logo
Guggenheim
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Boost Price TargetBuy$65.00 ➝ $92.00
9/28/2026
Tempus AI, Inc. stock logo
TEM
Tempus AI
Weiss Ratings logo
Weiss Ratings
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
DowngradeSell (D-) ➝ Sell (E+)
9/21/2026
Tempus AI, Inc. stock logo
TEM
Tempus AI
The Goldman Sachs Group, Inc. logo
The Goldman Sachs Group
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Initiated CoverageNeutral$75.00
9/21/2026
Tempus AI, Inc. stock logo
TEM
Tempus AI
The Goldman Sachs Group, Inc. logo
The Goldman Sachs Group
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Initiated CoverageNeutral$75.00
9/11/2026
Tempus AI, Inc. stock logo
TEM
Tempus AI
Weiss Ratings logo
Weiss Ratings
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
UpgradeSell (E+) ➝ Sell (D-)
9/11/2026
Tempus AI, Inc. stock logo
TEM
Tempus AI
HC Wainwright logo
HC Wainwright
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Boost Price TargetBuy$56.00 ➝ $66.00
9/9/2026
Tempus AI, Inc. stock logo
TEM
Tempus AI
UBS Group AG logo
UBS Group
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Initiated CoverageNeutral$70.00
9/8/2026
Tempus AI, Inc. stock logo
TEM
Tempus AI
Rothschild & Co Redburn logo
Rothschild & Co Redburn
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Initiated CoverageNeutral$67.00
9/8/2026
Tempus AI, Inc. stock logo
TEM
Tempus AI
Rothschild & Co Redburn logo
Rothschild & Co Redburn
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Initiated CoverageNeutral$67.00
9/8/2026
Tempus AI, Inc. stock logo
TEM
Tempus AI
Roth Capital logo
Roth Capital
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Initiated CoverageNeutral$67.00
(Data available from 10/6/2023 forward. View 10+ years of historical ratings with our analyst ratings screener.)
CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
ATT
Abattis Bioceuticals
N/AN/AN/AN/AN/AN/A
Tempus AI, Inc. stock logo
TEM
Tempus AI
$1.27B10.55N/AN/A$2.76 per share26.95
CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
ATT
Abattis Bioceuticals
N/AN/AN/AN/AN/AN/AN/AN/AN/A
Tempus AI, Inc. stock logo
TEM
Tempus AI
-$245.03M-$1.44N/AN/AN/A-17.77%-50.28%-10.33%11/3/2026 (Estimated)

Latest BGFD, TEM, MNKS, and ATT Earnings

DateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails
11/3/2026Q3 2026
Tempus AI, Inc. stock logo
TEM
Tempus AI
-$0.07N/AN/AN/A$409.42 millionN/A
7/30/2026Q2 2026
Tempus AI, Inc. stock logo
TEM
Tempus AI
-$0.1428-$0.04+$0.1028$0.03$379.69 million$382.49 million
CompanyAnnual PayoutDividend Yield5-Year Annualized Dividend GrowthPayout RatioYears of Consecutive Growth
ATT
Abattis Bioceuticals
N/AN/AN/AN/AN/A
Tempus AI, Inc. stock logo
TEM
Tempus AI
N/AN/AN/AN/AN/A
CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
ATT
Abattis Bioceuticals
N/AN/AN/A
Tempus AI, Inc. stock logo
TEM
Tempus AI
3.06
3.30
3.16

Institutional Ownership

CompanyInstitutional Ownership
ATT
Abattis Bioceuticals
N/A
Tempus AI, Inc. stock logo
TEM
Tempus AI
24.22%

Insider Ownership

CompanyInsider Ownership
ATT
Abattis Bioceuticals
N/A
Tempus AI, Inc. stock logo
TEM
Tempus AI
24.26%
CompanyEmployeesShares OutstandingFree FloatOptionable
ATT
Abattis Bioceuticals
N/AN/AN/ANot Optionable
Tempus AI, Inc. stock logo
TEM
Tempus AI
3,800180.43 million136.66 millionN/A

Recent News About These Companies

Top Artificial Intelligence Stocks To Add to Your Watchlist - October 6th
 |  americanbankingnews.comhttps://www.americanbankingnews.com/?p=31092754
Tempus AI (TEM) Shares Just Moved, So What Is Going On?
 |  finance.yahoo.comhttps://finance.yahoo.com/healthcare/articles/tempus-ai-tem-shares-just-050717020.html
Here's How Tempus AI is Capitalizing on AI-ECG Market Growth
October 5 at 12:06 PM  |  zacks.comhttps://www.zacks.com/stock/news/3000239/here-s-how-tempus-ai-is-capitalizing-on-ai-ecg-market-growth?cid=cs-stocknewsapi-ft-analyst_blog|quick_take-3000239
Artificial Intelligence Stocks To Watch Now - October 5th
October 5 at 12:01 PM  |  marketbeat.comhttps://www.marketbeat.com/instant-alerts/list-artificial-intelligence-stocks-to-watch-now-october-5th-2026-10-05/
Best Artificial Intelligence Stocks Worth Watching - October 3rd
October 5 at 1:02 AM  |  americanbankingnews.comhttps://www.americanbankingnews.com/?p=31085323
Promising Artificial Intelligence Stocks To Add to Your Watchlist - October 4th
October 4 at 12:01 PM  |  marketbeat.comhttps://www.marketbeat.com/instant-alerts/list-promising-artificial-intelligence-stocks-to-add-to-your-watchlist-october-4th-2026-10-04/
Consensus price target for Tempus AI increased by 17.40% to MX$1,423.09
October 2, 2026  |  msn.comhttps://www.msn.com/en-us/news/other/consensus-price-target-for-tempus-ai-increased-by-1740-to-mx-142309/ar-AA2doFY8
Tempus AI (NASDAQ:TEM) Shares Down 6.1% - Here's Why
October 1, 2026  |  marketbeat.comhttps://www.marketbeat.com/instant-alerts/price-tempus-ai-nasdaq-tem-shares-down-61-heres-why-2026-10-01/
Artificial Intelligence Stocks To Follow Today - October 1st
October 1, 2026  |  marketbeat.comhttps://www.marketbeat.com/instant-alerts/list-artificial-intelligence-stocks-to-follow-today-october-1st-2026-10-01/
10 Stocks With Massive Short Squeeze Potential
October 1, 2026  |  schaeffersresearch.comhttps://www.schaeffersresearch.com/content/analysis/2026/10/01/10-stocks-with-massive-short-squeeze-potential
Tempus Announces 13 Abstracts Accepted for Presentation at the European Society for Medical Oncology Congress 2026
October 1, 2026  |  businesswire.comhttps://www.businesswire.com/news/home/20261001487815/en/tempus-announces-13-abstracts-accepted-for-presentation-at-the-european-society-for-medical-oncology-congress-2026/
The Top HealthTech Questions Landing on Our Desks
September 30, 2026  |  etftrends.comE
Top Artificial Intelligence Stocks To Consider - September 28th
September 30, 2026  |  americanbankingnews.comhttps://www.americanbankingnews.com/?p=31066915
Best Artificial Intelligence Stocks To Consider - September 29th
September 29, 2026  |  marketbeat.comhttps://www.marketbeat.com/instant-alerts/list-best-artificial-intelligence-stocks-to-consider-september-29th-2026-09-29/
Best Artificial Intelligence Stocks Worth Watching - September 27th
September 29, 2026  |  americanbankingnews.comhttps://www.americanbankingnews.com/?p=31061894
FDA clears AI tool for detecting undiagnosed heart valve disease in ECGs
September 28, 2026  |  cardiovascularbusiness.comC
Tempus AI, Inc. Receives FDA Clearance For Tempus ECG-MR AI Product Designed To Identify Undiagnosed Mitral Regurgitation
September 28, 2026  |  marketscreener.comM
Tempus Secures FDA Clearance For ECG-AI Software Designed To Detect Mitral Regurgitation
September 28, 2026  |  rttnews.comhttps://www.rttnews.com/3694438/tempus-secures-fda-clearance-for-ecg-ai-software-designed-to-detect-mitral-regurgitation.aspx
Tempus Receives FDA Clearance for its ECG-MR AI Product Designed to Identify Undiagnosed Mitral Regurgitation
September 28, 2026  |  marketscreener.comM
Tempus AI (NASDAQ:TEM) CEO Sells $19,367,500.00 in Stock
September 27, 2026  |  americanbankingnews.comhttps://www.americanbankingnews.com/?p=31054622
Artificial Intelligence Stocks To Watch Today - September 26th
September 26, 2026  |  marketbeat.comhttps://www.marketbeat.com/instant-alerts/list-artificial-intelligence-stocks-to-watch-today-september-26th-2026-09-26/

New MarketBeat Followers Over Time

Media Sentiment Over Time

Top Headlines

View All Headlines
Autonomous military drone with AV-style logo on the nose sitting on a runway, representing AeroVironment and the defense drone industry.
AeroVironment's Record Backlog and Earnings Beat Fuel Recovery Case
By Thomas Hughes | September 10, 2026
An oil tanker anchored near a port terminal with storage tanks and hills visible in the background.
The Fed’s Rate Hike Could Backfire If Oil Prices Collapse
By Thomas Hughes | September 17, 2026
Digital illustration of a central computer chip connected by glowing blue and green lines to server nodes over a world map.
These 3 Stocks Sit at the Center of NVIDIA’s Cybersecurity Push
By Thomas Hughes | September 20, 2026
Server hardware in a data center rack featuring a processor chip labeled with the Arm logo.
Meta’s Muse Highlights Arm’s Growing Role in AI Infrastructure
By Jeffrey Neal Johnson | September 22, 2026
Three military surveillance drones fly near a mobile radar unit at an airfield during sunset.
3 Defense Stocks Riding the High-Energy Laser Boom
By Nathan Reiff | September 15, 2026

Abattis Bioceuticals CNSX:ATT

Abattis Bioceuticals Corp. is a specialty biotechnology company. The Company aggregates, incubates, integrates and invests in the natural health product and botanical drug development industry. It operates through the segment of producing, licensing and marketing ingredients and formulas for use in the biopharma, nutraceutical, cosmetic and animal nutrition markets. The Company, through its subsidiaries, develops and commercializes natural health (nutraceutical) products, and conducts research and development to create plant-based (botanical) intellectual property and ingredients for the pharmaceutical and bioceutical markets, among others. It offers products and services, such as botanical blends and formulas; cannabidiol ingredients; functional foods and beverages, and analytical services. It is focused on creating botanical formulations, medical marijuana and specialized health products for pain caused by inflammation, and mental ailments.

Tempus AI stock logo

Tempus AI NASDAQ:TEM

$74.39 -9.16 (-10.96%)
As of 12:47 PM Eastern
This is a fair market value price provided by Massive. Learn more.

Tempus AI Inc. is a technology company advancing precision medicine through the practical application of artificial intelligence principally in healthcare. The company provides AI-enabled precision medicine solutions to physicians to deliver personalized patient care and in parallel facilitates discovery, development and delivery of optimal therapeutics. Tempus AI Inc. is based in CHICAGO.

Stock Comparison Ideas (A-K)

Stock Comparison Ideas (L-Z)

Stock Lists
Low Priced Stocks
Stocks By Exchange
Latest Stock Ideas